
Sight Sciences Reports Preliminary Fourth Quarter 2025 Revenue Growth, Provides 2026 Outlook
Published on March 6, 2026
MENLO PARK, Calif.—Sight Sciences Inc. (Nasdaq: SGHT), an eyecare technology company, reported select preliminary, unaudited financial highlights for the fourth quarter and full year ended December 31, 2025. Fourth-quarter 2025 total revenue reached $20.4 million, an increase of 7 percent compared with the same period in 2024. Full-year 2025 total revenue was $77.4 million, a decrease of 3 percent compared with full-year 2024, the announcement noted. The company said it expects full-year 2026 revenue to range from $82 million to $88 million, representing growth of 6 percent to 14 percent compared with full-year 2025.
